Alzheimer's families just lost one of their biggest hopes
Acumen Pharmaceuticals Inc ABOS
$0.24
▼ -0.76%
($0.00)
Open
$0.23
Prev Close
$0.24
Day Range
$0.23 – $0.25
52W Range
$0.19 – $3.60
Market Cap
$17.14M
Beta
0.48
EPS (TTM)
$-1.63
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-01 |
| Shares Out. | 72,330,000 |
| Website | acumenpharm.com/ ↗ |
| Phone | 16173444190 |
| Employees | 61 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$25.4M |
| Free Cash Flow | -$88.0M |
| Total Assets | $85.6M |
| Total Liabilities | $51.0M |
| Equity | $34.6M |
About Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Acumen Pharmaceuticals Inc is a publicly traded company under the ticker symbol ABOS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-11-01)
📰 Latest News for ABOS
Unusual-Volume Stocks: Latest Session's Sharp Declines and Double-Digit Gains
Acumen Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
US Unusual Volume Stocks: ONEG, CENN, SLGB and INLF in Latest Scan
Small-Cap Market Movers: Top Gainers and Losers on Nov. 2, 2026
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday